Attached files

file filename
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR33.htm
EX-32 - EXHIBIT 32.1 - IRIS BIOTECHNOLOGIES INCirsb11132012exh321.htm
EX-31 - EXHIBIT 31.1 - IRIS BIOTECHNOLOGIES INCirsb11132012exh311.htm
EXCEL - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCFinancial_Report.xls
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR2.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR7.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR3.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR4.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR8.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR1.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR9.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR32.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR25.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR23.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR27.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR10.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR19.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR34.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR16.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR14.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR18.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR28.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR17.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR11.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR12.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR15.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR26.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR29.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR24.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR30.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR31.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR22.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR13.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR21.htm
10-Q - FORM 10-Q - IRIS BIOTECHNOLOGIES INCirsb11082012form10q.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR6.htm
XML - IDEA: XBRL DOCUMENT - IRIS BIOTECHNOLOGIES INCR20.htm
v2.4.0.6
CONDENSED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) (USD $)
Preferred shares
Common shares
Additional Paid-in Capital
Common stock Subscription
Subscription Receivable
Deficit accumulated during Development stage
Total
Balance, December 31, 2011, Amount at Dec. 31, 2011    $ 6,477,603 $ 2,288,376    $ (128,375) $ (8,605,721) $ 31,883
Balance, December 31, 2011, Stock at Dec. 31, 2011    12,605,573               
Common stock issued in January 2012 at $0.80 per share for services rendered, Stock    8,000               
Common stock issued in January 2012 at $0.80 per share for services rendered, Amount    6,400             6,400
Common stock issued in January 2012 at $0.60 per share for accruals, Stock    37,500               
Common stock issued in January 2012 at $0.60 per share for accruals, Amount    22,500             22,500
Common stock issued in February 2012 at $0.80 per share for services rendered, Stock    8,000               
Common stock issued in February 2012 at $0.80 per share for services rendered, Amount    6,400             6,400
Common stock issued in March 2012 at $0.80 per share for services rendered, Stock    8,000               
Common stock issued in March 2012 at $0.80 per share for services rendered, Amount    6,400             6,400
Common stock issued in April 2012 at $0.57 per share for services rendered, Stock    8,000               
Common stock issued in April 2012 at $0.57 per share for services rendered, Amount    4,560             4,560
Common stock issued in April 2012 at $0.80 per share for services rendered, Stock    35,700               
Common stock issued in April 2012 at $0.80 per share for services rendered, Amount    30,000             30,000
Common stock issued in May 2012 at $0.35 per share for services rendered, Stock    8,000               
Common stock issued in May 2012 at $0.35 per share for services rendered, Amount    2,800             2,800
Common stock issued in June 2012 at $0.41 per share for services rendered, Stock    8,000               
Common stock issued in June 2012 at $0.41 per share for services rendered, Amount    3,280             3,280
Sale of common stock in June 2012 at $1.00 per share, Stock    40,000               
Sale of common stock in June 2012 at $1.00 per share, Amount    40,000             40,000
Common stock issued in July 2012 at $0.40 per share for services rendered, Stock    8,000               
Common stock issued in July 2012 at $0.40 per share for services rendered, Amount    3,200             3,200
Common stock issued in July 2012 at $0.44 per share for services rendered, Stock    37,500               
Common stock issued in July 2012 at $0.44 per share for services rendered, Amount    16,500             16,500
Sale of common stock in July 2012 at $1.00 per share, Stock    10,000               
Sale of common stock in July 2012 at $1.00 per share, Amount    10,000             10,000
Common stock issued in August 2012 at $0.38 per share for services rendered, Stock    8,000               
Common stock issued in August 2012 at $0.38 per share for services rendered, Amount    3,061             3,061
Sale of common stock in August 2012 at $1.00 per share, Stock    40,000               
Sale of common stock in August 2012 at $1.00 per share, Amount    40,000             40,000
Proceeds received from common stock subscriptions          30,000       30,000
Fair value of vesting options for services       101,404          101,404
Net Loss                (430,500) (430,500)
Balance, September 30, 2012, Amount at Sep. 30, 2012    $ 6,672,704 $ 2,389,780 $ 30,000 $ (128,375) $ (9,036,221) $ (72,112)
Balance, September 30, 2012, Stock at Sep. 30, 2012    12,872,073